Logotype for Advanced Flower Capital Inc

Advanced Flower Capital (AFCG) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Advanced Flower Capital Inc

Q2 2025 earnings summary

10 Mar, 2026

Executive summary

  • Announced intention to convert from a REIT to a BDC to expand investment opportunities beyond real estate-backed cannabis operators, subject to shareholder approval, with conversion targeted for Q1 2026.

  • Board approved an expanded investment mandate to include direct lending outside the cannabis industry, aiming for greater diversification and risk-adjusted returns.

  • Reported GAAP net loss of $13.2 million for Q2 2025, with distributable earnings of $3.4 million.

  • Management remains focused on managing underperforming loans, maximizing recoveries, and resolving non-accrual credits, with ongoing legal actions and asset liquidations.

  • First Nasdaq-listed commercial mortgage REIT focused on institutional loans to state-compliant cannabis operators, with $917 million total commitments since inception.

Financial highlights

  • Q2 2025 distributable earnings were $3.4 million ($0.15 per share); GAAP net loss was $13.2 million ($0.60 per share).

  • Q2 2025 interest income was $8.1 million, net interest income was $6.2 million.

  • Book value per share was $8.18 as of June 30, 2025.

  • Paid a $0.15 per share dividend for Q2 2025.

  • Total assets as of June 30, 2025 were $298.6 million; shareholder equity was $184.7 million.

Outlook and guidance

  • Conversion to BDC expected to broaden the investment universe, allowing lending to non-real estate and ancillary cannabis businesses, and to other middle-market companies.

  • Management anticipates the need to raise additional equity and/or debt to support expanded investment focus and increased loan demand.

  • If federal rescheduling of cannabis occurs, management anticipates increased capital inflows and improved recoveries on troubled loans.

  • Pipeline of new investments has declined due to limited real estate-backed opportunities and tighter underwriting standards amid industry volatility.

  • Positioned to capitalize on a growing U.S. cannabis market projected to reach $63 billion by 2030, with a 12% CAGR.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more